Clin Ophthalmol:治疗链球菌性眼内炎的预测因素研究

2018-05-27 cuiguizhong MedSci原创

泰国孔敬大学医学院眼科学系的Yospaiboon Y近日在Clin Ophthalmol发表了一篇文章,他们评估了在2012-2016年期间泰国东北部大型转诊眼中心对链球菌引起的感染性眼内炎的视觉的治疗结果,并分析可能的预测因素。

泰国孔敬大学医学院眼科学系的Yospaiboon Y近日在Clin Ophthalmol发表了一篇文章,他们评估了在2012-2016年期间泰国东北部大型转诊眼中心对链球菌引起的感染性眼内炎的视觉的治疗结果,并分析可能的预测因素。

对由链球菌引起的眼内炎患者进行回顾性病历研究。收集并分析相关数据,包括年龄、性别、职业、症状持续时间、手术时间、手术程序,、现时的初始视力和治疗后的最终视力等。也研究了与改善视觉治疗效果有关的可能的预测因素。

他们对45名患者的45只眼睛进行研究。最常见的3种眼内炎类型为术后(35.56%)、创伤后(20%)和内源性(15.56%)眼内炎。大多数患者(95.56%)视力为手部运动(55.56%)、光线感知(28.89%)或无光感(11.11%)等级。 眼内炎中最常见的3种分离株为肺炎链球菌(44.44%)、B组溶血性链球菌(26.68%)和草绿色链球菌(20%)。大多数患者(62.22%)接受了手术治疗,包括玻璃体切除术和玻璃体内抗生素治疗,玻璃体切除术以及硅油填充。治疗后,只有9例患者(20%)出现视力改善,36例患者(80%)没有发现视力得到改善。 15例(33.33%)患者进行了剔骨和眼球摘除术。与改善视力结果相关的唯一可能的预测因素是在3天内进行的早期玻璃体切割术。

因此,作者认为,链球菌性眼内炎通常与视力不良的预后相关。治疗后仅有9例患者(20%)的视力改善。与改善视力结果相关的唯一可能的预测因素是3天内进行的玻璃体切割术。这项研究提示,早期诊断和早期玻璃体切割术对于改善眼内炎有重要的作用。

原文出处:

Yospaiboon, Y., et al., Predictive factors in the treatment of streptococcal endophthalmitis. Clin Ophthalmol, 2018. 12: p. 859-864.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1693389, encodeId=d1481693389e9, content=<a href='/topic/show?id=84a9e272175' target=_blank style='color:#2F92EE;'>#眼内炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72721, encryptionId=84a9e272175, topicName=眼内炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ee29418707, createdName=liuyong2990, createdTime=Wed Oct 03 22:56:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264291, encodeId=5f331264291cc, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541353, encodeId=2c0715413539a, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624060, encodeId=484116240609f, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319129, encodeId=8e033191293b, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun May 27 20:42:46 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1693389, encodeId=d1481693389e9, content=<a href='/topic/show?id=84a9e272175' target=_blank style='color:#2F92EE;'>#眼内炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72721, encryptionId=84a9e272175, topicName=眼内炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ee29418707, createdName=liuyong2990, createdTime=Wed Oct 03 22:56:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264291, encodeId=5f331264291cc, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541353, encodeId=2c0715413539a, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624060, encodeId=484116240609f, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319129, encodeId=8e033191293b, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun May 27 20:42:46 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1693389, encodeId=d1481693389e9, content=<a href='/topic/show?id=84a9e272175' target=_blank style='color:#2F92EE;'>#眼内炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72721, encryptionId=84a9e272175, topicName=眼内炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ee29418707, createdName=liuyong2990, createdTime=Wed Oct 03 22:56:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264291, encodeId=5f331264291cc, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541353, encodeId=2c0715413539a, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624060, encodeId=484116240609f, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319129, encodeId=8e033191293b, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun May 27 20:42:46 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-29 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1693389, encodeId=d1481693389e9, content=<a href='/topic/show?id=84a9e272175' target=_blank style='color:#2F92EE;'>#眼内炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72721, encryptionId=84a9e272175, topicName=眼内炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ee29418707, createdName=liuyong2990, createdTime=Wed Oct 03 22:56:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264291, encodeId=5f331264291cc, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541353, encodeId=2c0715413539a, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624060, encodeId=484116240609f, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319129, encodeId=8e033191293b, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun May 27 20:42:46 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1693389, encodeId=d1481693389e9, content=<a href='/topic/show?id=84a9e272175' target=_blank style='color:#2F92EE;'>#眼内炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72721, encryptionId=84a9e272175, topicName=眼内炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ee29418707, createdName=liuyong2990, createdTime=Wed Oct 03 22:56:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264291, encodeId=5f331264291cc, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541353, encodeId=2c0715413539a, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624060, encodeId=484116240609f, content=<a href='/topic/show?id=69699666026' target=_blank style='color:#2F92EE;'>#链球菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96660, encryptionId=69699666026, topicName=链球菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787f20641298, createdName=liuquanmn, createdTime=Tue May 29 10:56:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319129, encodeId=8e033191293b, content=^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun May 27 20:42:46 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-27 wqkm

    ^_^^_^^_^

    0

相关资讯

PLOS Pathog:研究发现:细菌促进结肠直肠癌症的生长

最近的一项研究发现,一种细菌能促进结肠直肠癌的生长,而这是导致癌症死亡的第二大原因。

人类罕见病例:链球菌感染如何导致截肢?

据 CNN 报道,44 岁的 Kevin Breen 在 12 月下旬第一次去了急诊室,在检查之后,发现有流感样症状和胃痛。随后他的胃开始扩大,紧接着他被带入了手术室,进行手术。医生在他的器官周围发现了大量的脓液,但他们并不知道他的病因到底是什么。

J Oral Microbiol:群体感应干扰剂可抑制链球菌菌膜的形成

既往研究已经提出将群体感应信号AI-2作为潜在靶标来防止变形链球菌(一种参与龋齿的病原体)形成生物膜。本研究旨在使用从海洋粘着杆菌20J获得的提取物干扰AI-2群体感应系统来抑制变形链球菌生物膜形成。使用生物传感器哈氏弧菌BB170和JMH597测试AI-2抑制活性。使用xCELLigence系统的阻抗实时测量、共焦激光显微镜和结晶紫定量方法,监测变形链球菌ATCC25175生物膜的形成。结果显示

J Antimicrob Chemother:链球菌耐药在逐渐增加?

近期,J Antimicrob Chemother杂志中有一篇文章报道,链球菌耐药的频率在逐渐的上升,我们应该要引起重视。在美国,无乳链球菌(GBS)是引起脑膜炎、败血症、新生儿肺炎的一个主要原因。也可导致导致老年人及处于医疗环境中的大龄婴儿、孕妇、儿童、年轻人的侵袭性疾病。对林可霉素类耐药而对红霉素不耐药的GBS很少见。但是,先前在却有这样的临床分离菌株的报道,同时对链阳霉素A及截短侧耳素均耐药

8分钟检测A群链球菌感染  Alere分子诊断试剂获FDA批准

美艾利尔(Alere)公司开发的诊断试剂Alere i Strep A test日前获得了FDA批准,用于A群链球菌的检测,最多8分钟就能从咽拭子标本中检测出患者是否发生感染。   “Alere i Strep A test能让临床诊断变得快速、高效、准确,及时给出恰当的治疗方案。避免盲目滥用抗生素,提高患者治愈率。”美艾利尔传染病业务部全球总监Avi Pelossof在新闻发布